Medicenna Therapeutics, Inc.
MDNA · TSX
Public Market Listing
MDNATSX
Live quotes, historical charts, and market capitalization for Medicenna Therapeutics, Inc. are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
bizaxofuspNo recent activity | Phase 2 | IL-4 receptor (IL-4R)Protein / enzyme therapeutic | Glioblastoma Recurrent Glioblastoma |
| Phase 1/2 | IL-2 receptorProtein / enzyme therapeutic | Non-Small Cell Lung Cancer |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Financial reports
No financial reports recorded.